annual cash & cash equivalents:
$104.42M+$22.42M(+27.34%)Summary
- As of today (July 7, 2025), MDXG annual cash & cash equivalents is $104.42 million, with the most recent change of +$22.42 million (+27.34%) on December 31, 2024.
- During the last 3 years, MDXG annual cash & cash equivalents has risen by +$17.33 million (+19.90%).
- MDXG annual cash & cash equivalents is now at all-time high.
Performance
MDXG Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$106.43M+$2.02M(+1.93%)Summary
- As of today (July 7, 2025), MDXG quarterly cash & cash equivalents is $106.43 million, with the most recent change of +$2.02 million (+1.93%) on March 31, 2025.
- Over the past year, MDXG quarterly cash & cash equivalents has increased by +$57.94 million (+119.50%).
- MDXG quarterly cash & cash equivalents is now -2.89% below its all-time high of $109.59 million, reached on September 30, 2020.
Performance
MDXG quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MDXG Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | +119.5% |
| 3 y3 years | +19.9% | +40.6% |
| 5 y5 years | +51.2% | +98.8% |
MDXG Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.3% | at high | +119.5% |
| 5 y | 5-year | at high | +58.3% | -2.9% | +120.9% |
| alltime | all time | at high | >+9999.0% | -2.9% | >+9999.0% |
MDXG Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $106.43M(+1.9%) |
| Dec 2024 | $104.42M(+27.3%) | $104.42M(+17.6%) |
| Sep 2024 | - | $88.80M(+28.6%) |
| Jun 2024 | - | $69.04M(+42.4%) |
| Mar 2024 | - | $48.49M(-40.9%) |
| Dec 2023 | $82.00M(+24.3%) | $82.00M(+1.0%) |
| Sep 2023 | - | $81.16M(+18.2%) |
| Jun 2023 | - | $68.65M(+12.1%) |
| Mar 2023 | - | $61.22M(-7.2%) |
| Dec 2022 | $65.95M(-24.3%) | $65.95M(-9.9%) |
| Sep 2022 | - | $73.22M(+1.0%) |
| Jun 2022 | - | $72.50M(-4.2%) |
| Mar 2022 | - | $75.68M(-13.1%) |
| Dec 2021 | $87.08M(-9.1%) | $87.08M(-3.9%) |
| Sep 2021 | - | $90.61M(+6.6%) |
| Jun 2021 | - | $85.01M(+0.3%) |
| Mar 2021 | - | $84.75M(-11.5%) |
| Dec 2020 | $95.81M(+38.7%) | $95.81M(-12.6%) |
| Sep 2020 | - | $109.59M(+127.4%) |
| Jun 2020 | - | $48.19M(-10.0%) |
| Mar 2020 | - | $53.52M(-22.5%) |
| Dec 2019 | $69.07M(+53.1%) | $69.07M(-26.6%) |
| Sep 2019 | - | $94.12M(-2.9%) |
| Jun 2019 | - | $96.93M(+241.5%) |
| Mar 2019 | - | $28.38M(-37.1%) |
| Dec 2018 | $45.12M(+64.2%) | $45.12M(+64.2%) |
| Dec 2017 | $27.48M(-20.1%) | $27.48M(-24.8%) |
| Sep 2017 | - | $36.52M(-23.2%) |
| Jun 2017 | - | $47.53M(+53.7%) |
| Mar 2017 | - | $30.92M(-10.1%) |
| Dec 2016 | $34.39M(+20.7%) | $34.39M(+87.5%) |
| Sep 2016 | - | $18.34M(-23.0%) |
| Jun 2016 | - | $23.80M(+57.5%) |
| Mar 2016 | - | $15.12M(-46.9%) |
| Dec 2015 | $28.49M | $28.49M(-30.6%) |
| Sep 2015 | - | $41.07M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $38.60M(-0.2%) |
| Mar 2015 | - | $38.70M(-16.9%) |
| Dec 2014 | $46.58M(+5.7%) | $46.58M(-1.4%) |
| Sep 2014 | - | $47.25M(+20.4%) |
| Jun 2014 | - | $39.25M(-8.8%) |
| Mar 2014 | - | $43.02M(-2.4%) |
| Dec 2013 | $44.08M(+552.6%) | $44.08M(+627.1%) |
| Sep 2013 | - | $6.06M(+44.5%) |
| Jun 2013 | - | $4.19M(-26.8%) |
| Mar 2013 | - | $5.73M(-15.2%) |
| Dec 2012 | $6.75M(+64.3%) | $6.75M(-11.4%) |
| Sep 2012 | - | $7.62M(+187.1%) |
| Jun 2012 | - | $2.65M(-12.1%) |
| Mar 2012 | - | $3.02M(-26.5%) |
| Dec 2011 | $4.11M(+206.7%) | $4.11M(+545.4%) |
| Sep 2011 | - | $637.20K(-60.5%) |
| Jun 2011 | - | $1.61M(+58.2%) |
| Mar 2011 | - | $1.02M(-23.9%) |
| Dec 2010 | $1.34M(-49.5%) | $1.34M(+212.9%) |
| Sep 2010 | - | $428.50K(-84.3%) |
| Jun 2010 | - | $2.73M(+67.6%) |
| Mar 2010 | - | $1.63M(>+9900.0%) |
| Dec 2009 | $2.65M(+7525.0%) | - |
| Sep 2009 | - | $5800.00(-99.6%) |
| Jun 2009 | - | $1.62M(+4557.8%) |
| Mar 2009 | - | $34.80K(-96.0%) |
| Mar 2009 | $34.80K(-99.5%) | - |
| Dec 2008 | - | $864.80K(-63.2%) |
| Sep 2008 | - | $2.35M(-39.4%) |
| Jun 2008 | - | $3.88M(>+9900.0%) |
| Mar 2008 | $6.75M(>+9900.0%) | - |
| Dec 2007 | $200.00(-96.9%) | $200.00(-85.7%) |
| Sep 2007 | - | $1400.00(-90.5%) |
| Jun 2007 | - | $14.70K(+716.7%) |
| Mar 2007 | - | $1800.00 |
| Dec 2006 | $6400.00 | - |
FAQ
- What is MiMedx Group, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. annual cash & cash equivalents year-on-year change?
- What is MiMedx Group, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. quarterly cash & cash equivalents year-on-year change?
What is MiMedx Group, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MDXG is $104.42M
What is the all time high annual cash & cash equivalents for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high annual cash & cash equivalents is $104.42M
What is MiMedx Group, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MDXG annual cash & cash equivalents has changed by +$22.42M (+27.34%)
What is MiMedx Group, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MDXG is $106.43M
What is the all time high quarterly cash & cash equivalents for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high quarterly cash & cash equivalents is $109.59M
What is MiMedx Group, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MDXG quarterly cash & cash equivalents has changed by +$57.94M (+119.50%)